1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Generics in Singapore

Generics in Singapore

  • January 2017
  • -
  • MarketLine
  • -
  • 31 pages

Summary

Table of Contents

Search Inside

Summary
Generics in Singapore industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Singapore
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Singapore
- Leading company profiles reveal details of key generics market players' global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Singapore generics market with five year forecasts by both value and volume

Synopsis
Essential resource for top-line data and analysis covering the Singapore generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons To Buy
- What was the size of the Singapore generics market by value in 2016?
- What will be the size of the Singapore generics market in 2021?
- What factors are affecting the strength of competition in the Singapore generics market?
- How has the market performed over the last five years?
- How large is Singapore's generics market in relation to its regional counterparts?

Key Findings
For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

The Singaporean generics market is expected to generate total revenues of $0.3bn in 2016, representing a compound annual growth rate (CAGR) of 8.4% between 2012 and 2016.

Market consumption volume is forecast to decline with a CARC of -0.2% between 2012 and 2016, to reach a total of 87.9% of total pharma volume in 2016.

Singapore has a well-developed pharmaceutical market. The company's average purchasing power parity (PPP) per capita of GDP was over $61,000 in 2013, $10,000 more than in the US. The country has also been ranked number six healthcare system worldwide by the World Health Organization.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • April 2017
    44 pages
  • Therapy  

    Serotonin Speci...  

    Antidepressant  

  • United States  

View report >

Therapy Market and Monoclonal Antibody Market in the Netherlands

  • April 2017
    13 pages
  • Therapy  

    Monoclonal Anti...  

    Targeted Therap...  

  • Netherlands  

View report >

Stroke Statistics in the US

  • April 2017
    4 pages
  • Stroke  

    Blood Disease  

  • United States  

View report >

Related Market Segments :

Pharmaceutical

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.